ロード中...
Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Toll-like receptor 4 (TLR4) is ubiquitously expressed on parenchymal and immune cells of the liver and is the most studied TLR responsible for the activation of proinflammatory signaling cascades in liver ischemia and reperfusion (I/R). Since pharmacological inhibition of TLR4 during the sterile inf...
保存先:
| 出版年: | Mol Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
ScholarOne
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4365061/ https://ncbi.nlm.nih.gov/pubmed/25375408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2014.00076 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|